These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 26603303
1. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats. Liu Y, Rui Y, Cheng TY, Huang S, Xu L, Meng F, Lee WY, Zhang T, Li N, Li C, Ke H, Li G. Calcif Tissue Int; 2016 Mar; 98(3):263-74. PubMed ID: 26603303 [Abstract] [Full Text] [Related]
2. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats. Stolina M, Dwyer D, Niu QT, Villasenor KS, Kurimoto P, Grisanti M, Han CY, Liu M, Li X, Ominsky MS, Ke HZ, Kostenuik PJ. Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263 [Abstract] [Full Text] [Related]
3. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody. Li X, Niu QT, Warmington KS, Asuncion FJ, Dwyer D, Grisanti M, Han CY, Stolina M, Eschenberg MJ, Kostenuik PJ, Simonet WS, Ominsky MS, Ke HZ. Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718 [Abstract] [Full Text] [Related]
4. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats. Suen PK, He YX, Chow DH, Huang L, Li C, Ke HZ, Ominsky MS, Qin L. J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158 [Abstract] [Full Text] [Related]
5. Inhibition of sclerostin by systemic treatment with sclerostin antibody enhances healing of proximal tibial defects in ovariectomized rats. McDonald MM, Morse A, Mikulec K, Peacock L, Yu N, Baldock PA, Birke O, Liu M, Ke HZ, Little DG. J Orthop Res; 2012 Oct; 30(10):1541-8. PubMed ID: 22457198 [Abstract] [Full Text] [Related]
6. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats. Feng G, Chang-Qing Z, Yi-Min C, Xiao-Lin L. Int Immunopharmacol; 2015 Jan; 24(1):7-13. PubMed ID: 25479724 [Abstract] [Full Text] [Related]
7. Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis. Chen H, Xu X, Liu M, Zhang W, Ke HZ, Qin A, Tang T, Lu E. Bone; 2015 Jul; 76():141-8. PubMed ID: 25868799 [Abstract] [Full Text] [Related]
8. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats. Li X, Ominsky MS, Warmington KS, Niu QT, Asuncion FJ, Barrero M, Dwyer D, Grisanti M, Stolina M, Kostenuik PJ, Simonet WS, Paszty C, Ke HZ. Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832 [Abstract] [Full Text] [Related]
9. Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Tian X, Jee WS, Li X, Paszty C, Ke HZ. Bone; 2011 Feb; 48(2):197-201. PubMed ID: 20850580 [Abstract] [Full Text] [Related]
10. The effects of sclerostin antibody plus parathyroid hormone (1-34) on bone formation in ovariectomized rats. Wu J, Cai XH, Qin XX, Liu YX. Z Gerontol Geriatr; 2018 Jul; 51(5):550-556. PubMed ID: 28364259 [Abstract] [Full Text] [Related]
11. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis. Li X, Ominsky MS, Villasenor KS, Niu QT, Asuncion FJ, Xia X, Grisanti M, Wronski TJ, Simonet WS, Ke HZ. Endocrinology; 2018 Jan 01; 159(1):260-271. PubMed ID: 29069393 [Abstract] [Full Text] [Related]
16. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse. Zhang D, Hu M, Chu T, Lin L, Wang J, Li X, Ke HZ, Qin YX. Bone; 2016 Jun 01; 87():161-8. PubMed ID: 26868528 [Abstract] [Full Text] [Related]
17. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model. Virk MS, Alaee F, Tang H, Ominsky MS, Ke HZ, Lieberman JR. J Bone Joint Surg Am; 2013 Apr 17; 95(8):694-701. PubMed ID: 23595067 [Abstract] [Full Text] [Related]
18. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat. Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA. Bone; 2014 Jan 17; 58():151-9. PubMed ID: 24125756 [Abstract] [Full Text] [Related]